Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL NASDAQ:AVAH NASDAQ:CDNA NASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$2.23-3.7%$2.48$1.50▼$7.73$921.04M0.165.26 million shs742,208 shsAVAHAveanna Healthcare$4.14-2.2%$5.14$2.60▼$6.19$806.70M1.98347,062 shs81,411 shsCDNACareDx$20.22-2.0%$17.99$14.09▼$34.84$1.13B2.19921,568 shs441,920 shsVMDViemed Healthcare$6.94-0.6%$6.80$6.14▼$9.81$273.48M1.37145,113 shs42,825 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health+0.65%-3.38%+1.31%-59.28%-59.03%AVAHAveanna Healthcare-0.94%-8.54%-22.24%-5.79%+64.59%CDNACareDx+1.73%+7.48%+3.93%+9.68%+43.16%VMDViemed Healthcare0.00%-2.58%+1.16%+5.60%+9.75%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLAgilon Health2.1479 of 5 stars4.11.00.00.02.10.00.6AVAHAveanna Healthcare1.1627 of 5 stars2.02.00.00.02.42.50.0CDNACareDx4.4567 of 5 stars3.32.00.04.23.50.81.9VMDViemed Healthcare1.7128 of 5 stars0.03.00.00.01.83.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.17Hold$4.71106.95% UpsideAVAHAveanna Healthcare 2.00Hold$5.2025.76% UpsideCDNACareDx 2.67Moderate Buy$30.3349.20% UpsideVMDViemed Healthcare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VMD, CDNA, AGL, and AVAH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025AGLAgilon HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $3.007/2/2025AVAHAveanna HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$5.505/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/9/2025AVAHAveanna HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$4.50 ➝ $5.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLAgilon HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.005/5/2025CDNACareDxStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$40.00 ➝ $40.005/5/2025CDNACareDxHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$25.00 ➝ $25.004/28/2025AGLAgilon HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLAgilon HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.004/17/2025CDNACareDxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$34.00 ➝ $26.00(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.16N/AN/A$1.14 per share2.00AVAHAveanna Healthcare$2.02B0.40$0.16 per share26.04($0.64) per share-6.46CDNACareDx$333.79M3.39$1.36 per share14.91$7.06 per share2.88VMDViemed Healthcare$224.26M1.23$0.94 per share7.42$3.41 per share2.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)AVAHAveanna Healthcare-$10.93M$0.02207.00∞N/A0.26%-15.16%1.14%8/6/2025 (Estimated)CDNACareDx$52.55M$1.1517.64N/AN/A19.79%21.16%14.25%7/30/2025 (Estimated)VMDViemed Healthcare$11.27M$0.3023.17∞N/A5.28%9.49%7.14%8/6/2025 (Estimated)Latest VMD, CDNA, AGL, and AVAH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025AGLAgilon Health-$0.11N/AN/AN/A$1.47 billionN/A7/30/2025Q2 2025CDNACareDx$0.12N/AN/AN/A$90.72 millionN/A5/7/2025Q1 2025VMDViemed Healthcare$0.06$0.06N/A$0.06$60.60 million$59.10 million5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion4/30/2025Q1 2025CDNACareDx$0.06$0.09+$0.03-$0.19$84.56 million$84.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/AAVAHAveanna HealthcareN/AN/AN/AN/AN/ACDNACareDxN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.201.20AVAHAveanna HealthcareN/A1.051.05CDNACareDxN/A4.113.84VMDViemed Healthcare0.031.381.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/AAVAHAveanna Healthcare87.96%CDNACareDxN/AVMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%AVAHAveanna Healthcare7.80%CDNACareDx4.40%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionableAVAHAveanna Healthcare33,500195.09 million179.88 millionOptionableCDNACareDx74055.68 million53.23 millionOptionableVMDViemed Healthcare1,17939.52 million31.62 millionNot OptionableVMD, CDNA, AGL, and AVAH HeadlinesRecent News About These CompaniesLafayette’s Viemed completes $26 million acquisition of Illinois medical equipment firmJuly 9 at 7:55 PM | theadvertiser.comTViemed officially adds Lehan’s to familyJuly 7, 2025 | hmenews.comHViemed Healthcare (NASDAQ:VMD) Stock Price Up 1.2% - Time to Buy?July 4, 2025 | marketbeat.comViemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial ResultsJuly 2, 2025 | accessnewswire.comAInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares of StockJuly 1, 2025 | insidertrades.comInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares of StockJune 30, 2025 | marketbeat.comInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 34,100 Shares of StockJune 30, 2025 | marketbeat.comViemed Healthcare: Getting More AirJune 25, 2025 | seekingalpha.comViemed Healthcare, Inc. (NASDAQ:VMD) Shares Sold by Two Sigma Investments LPJune 12, 2025 | marketbeat.comviemed healthcare shareholders approve key amendments and director electionsJune 7, 2025 | investing.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMay 14, 2025 | finance.yahoo.comViemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comLake Street Keeps Their Buy Rating on Viemed Healthcare (VMD)May 9, 2025 | theglobeandmail.comViemed Healthcare Inc (VMD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 9, 2025 | finance.yahoo.comViemed Healthcare, Inc. Announces Definitive Agreement to Acquire Lehan's Medical EquipmentMay 8, 2025 | nasdaq.comViemed Healthcare, Inc. Reports Q1 2025 Financial Results and Updates Full Year GuidanceMay 7, 2025 | quiverquant.comQViemed Healthcare Announces First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comViemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in IllinoisMay 6, 2025 | globenewswire.comViemed Healthcare Announces First Quarter 2025 Earnings Conference Call DetailsApril 22, 2025 | globenewswire.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMarch 28, 2025 | insidermonkey.comViemed stays ‘nimble’March 15, 2025 | hmenews.comHNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVMD, CDNA, AGL, and AVAH Company DescriptionsAgilon Health NYSE:AGL$2.22 -0.09 (-3.68%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Aveanna Healthcare NASDAQ:AVAH$4.14 -0.10 (-2.25%) As of 12:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.CareDx NASDAQ:CDNA$20.22 -0.41 (-1.99%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.Viemed Healthcare NASDAQ:VMD$6.94 -0.04 (-0.57%) As of 12:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Plug Power’s 20% Surge Signals New Commercial Growth Era Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
